Calidi Biotherapeutics Inc (CLDI)
AMEX
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 2.923 | 2.571 | -110.512 |
Return on Equity (%) | -46.122 | -35.492 | 434.762 |
Return on Invested Capital (%) | 23.811 | 27.46 | 502.876 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 3.745 | 0.964 | -0.161 |
Earnings Per Share | 0.059 | 0.091 | -0.572 |
Cash Per Share | 0.018 | 0.002 | 0.038 |
Working Capital Per Share | 0.019 | -0.107 | -0.116 |
Operating Profit Per Share | N/A | -0.121 | N/A |
EBIT Per Share | 0.059 | 0.1 | -0.572 |
EBITDA Per Share | 0.059 | 0.1 | -0.572 |
Free Cash Flow Per Share | 0.059 | 0.091 | -0.568 |
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||||||
Actions en circulation | N/A | 4,13M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 17,66M |
Ratio cours/bénéfice | -0,6 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 9,06 |
Ratio prix/valeur comptable | -2,14 |
Rendement de dividende | - |
Actions en circulation | 13,08M |
Volume moyen (1 semaine) | 1,54M |
Volume moyen (1 mois) | 1,18M |
Variation sur 52 semaines | -93,04% |
Plus haut sur 52 semaines | 16,80 |
Plus bas sur 52 semaines | 0,73 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales